AIC’s Partner, Sanat Products Limited, Successfully Completed FDA Inspection
Framingham, MA — January 8, 2018— Sanat Products Limited has successfully completed an FDA site inspection for their Herbal Extract manufacturing facility based out of Sikandrabad, UP, India.
The inspection was done in the first week of December in which the FDA thoroughly reviewed Sanat’s Herbal Extract manufacturing, quality control and quality assurance procedures. The inspection confirmed the site to be compliant with the principles and guidelines of the FDA’s Quality System/Current Good Manufacturing Practices, and no Form 483 observations were issued.
Amit Sharma, Business Head and Director at Sanat, commented: “The success of the recent FDA inspection is a testament to the quality of our processes and ingredients we offer. We are delighted with the outcomes and look forward to increasing our sales into the US and helping our valued customers gain further approvals for finished products”.
Mark Robertson, Executive VP of Marketing at AIC, said “AIC is delighted with the positive audit results obtained by Sanat. These results are a statement as to the robust GMP program Sanat has established, setting them apart from the rest of the market”.
About Sanat Products Limited
Sanat Products Ltd. is an emerging innovation driven pharmaceutical company, headquartered in the Capital of India New Delhi. Established in the year 1984, the company is engaged in the manufacturing and marketing of pharmaceutical & nutraceuticals products. The company has Research and Development (R&D), manned by competent professionals at corporate office as well as at manufacturing plants. The Research & Development wing of Sanat Products Limited is duly recognized by the Department of Science and Technology, Government of India. Under the aegis of ISO 9001, its development activities are governed by the design clause of the Total Quality System.